Skip to main content
Equibles

TLSA · Tiziana Life Sciences Ltd

Track TLSA — free

Use TLSA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TLSA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.96 0.00 (-0.41%) At close · Sep 11
Rebalance outlook locked
Market Cap
$122.17M
Shares
127.26M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.96 Open$0.98 Day$0.93–1.00 52W close$0.89–2.29 Avg vol 30d950K Short int1.7M · 1.3% float · 1.7d Short vol42% DataJul 2020–Sep 2026

Raw chart and full-history price indicators begin at the captured split on Jul 31, 2020; bars on opposite sides are not compared.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+8.1%
Year over year · more shares
Price change (1Y)
-46.4%
Trailing year
Short interest
1.3%
Latest settlement · 1.7 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.8 · calm Equity put/call 0.58
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg −9%
below
RSI (14) 42
neutral
MACD trend Negative
52-week position 5%
near low
Momentum
relative strength
Very Weak
1-month return −8%
trailing
6-month return −21%
trailing
YTD return −36%
this year
Relative strength −39%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest Rising
1.34% of float · ▲ +0.0% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
31 holders — mid 3-yr range
Squeeze score 40
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 74%
annualized · 1-yr
Max drawdown −61%
past year
ATR 9.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
−9% Bearish
RSI (14)
42 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow Distributing
-6% holders QoQ · +5 funds added
Insider flow Accumulating
Net +$1.0M over 90 days · 0% sells
Short interest Rising
1.34% of float · ▲ +0.0% MoM · 1.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
31 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1 Now $1 · 5% Range high $2
vs 200-day avg -27% vs 50-day avg -9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TLSA
Tiziana Life Sciences Ltd
this stock
$122.17M -35.6% — — 1.3%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.64B +13.7% +46.2% 30.0 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $80.46B +1.2% +20.8% 19.4 2.5%
ARGX
Argenx SE
 $61.22B +17.1% — — 2.0%
MRNA
Moderna, Inc.
 $57.48B +388.2% +4.3% — 9.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
31
% held
1.9%
Net QoQ
-695.1K sh
Top holder
Dauntless Investment Grou…
Held Float
View
Short & Settlement
Short Interest Rising
Shares short
1.7M
Days to cover
1.7d
Change
+213 sh
View
Short Volume
Short vol %
42%
As of
Sep 11, 2026
Short Total
View
Fails to Deliver
FTD shares
8.5K
Value
$8.8K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
52.3%
Week of
Aug 3, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net buying
Net (90d)
+$1.0M
Buyers / Sellers
2 / 0
Buyers Sellers
View
Filings
SEC Filings
Latest
6-K
Filed
Aug 24, 2026
This year
20
View
Earnings & Events
Investor Relations
Latest news
Tiziana Life Sciences Announces P…
Published
Aug 24, 2026
View

Performance

Raw-price comparisons begin at the captured split on Jul 31, 2020; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
TLSA -1.5% -7.7% -20.7% -2.8% -35.6%
SPY -1.2% -1.8% +17.8% -0.4% +12.1%
vs SPY -0.3% -5.9% -38.5% -2.5% -47.7%
Key facts CIK 1723069 CUSIP G88912103 13F (30d) 11 filings 11 filers Visit website Investor relations